BRIEF published on 09/09/2025 at 05:55, 2 months 26 days ago Lobe Sciences Appoints Marco Mastrodonato to Board Biopharmaceutical Board Appointment Therapeutic Development Lobe Sciences Marco Mastrodonato
PRESS RELEASE published on 09/09/2025 at 05:50, 2 months 26 days ago Lobe Sciences Announces the Appointment of Marco Mastrodonato to its Board of Directors Lobe Sciences Ltd. appoints Marco Mastrodonato to its Board of Directors, bringing extensive experience in pharmaceutical and biotechnology industries, enhancing global business acumen Board Of Directors Pharmaceutical Industry Lobe Sciences Ltd. Marco Mastrodonato Biotechnology Industry
BRIEF published on 08/15/2025 at 05:05, 3 months 21 days ago Lobe Sciences conclut un placement privé pour lever 341 425 $ CA Placement Privé Biopharmaceutique Offre D'actions Marché Canadien Sciences Du Lobe
BRIEF published on 08/15/2025 at 05:05, 3 months 21 days ago Lobe Sciences Concludes Private Placement to Raise CAD $341,425 Private Placement Canadian Market Biopharmaceutical Equity Offering Lobe Sciences
PRESS RELEASE published on 08/15/2025 at 05:00, 3 months 21 days ago Lobe Sciences Announces the Closing of the Previously Announced Private Placement Lobe Sciences completes non-brokered private placement totaling $341,425 CAD. Securities subject to statutory holding period. Developing treatments for rare diseases Private Placement Biopharmaceutical Therapeutics Rare Diseases Lobe Sciences
BRIEF published on 07/29/2025 at 06:15, 4 months 7 days ago Lobe Sciences annonce un placement privé pour le financement des entreprises Placement Privé Investissements Biopharmaceutique Financement Des Entreprises Sciences Du Lobe
BRIEF published on 07/29/2025 at 06:15, 4 months 7 days ago Lobe Sciences Announces Private Placement for Corporate Funding Private Placement Biopharmaceutical Investments Corporate Funding Lobe Sciences
BRIEF published on 07/29/2025 at 06:13, 4 months 7 days ago Lobe Sciences Ltd. s'associe à ArcStone pour sa stratégie de marché Partenariat Stratégique Biopharmaceutique Marchés Financiers Relations Avec Les Investisseurs Positionnement Sur Le Marché
BRIEF published on 07/29/2025 at 06:13, 4 months 7 days ago Lobe Sciences Ltd. Partners with ArcStone for Market Strategy Investor Relations Strategic Partnership Capital Markets Biopharmaceutical Market Positioning
PRESS RELEASE published on 07/29/2025 at 06:10, 4 months 7 days ago Lobe Sciences Announces $341,425 CAD Private Placement for General Corporate Purposes Lobe Sciences announces non-brokered private placement offering of common shares for gross proceeds, focusing on therapeutics for rare diseases Private Placement Biopharmaceutical Therapeutics Rare Diseases Lobe Sciences
Published on 12/05/2025 at 02:35, 5 hours 35 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 10 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 5 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 10 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 08:01, 9 minutes ago Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:00, 10 minutes ago Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 07:00, 1 hour 10 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 40 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 19 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 18:14, 13 hours 55 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 10 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 10 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 25 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 25 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
